For its third fiscal quarter (ending September 30), CME Group Inc (NASDAQ: CME) has reported E.P.S. of $2.51 compared to $2.06 a year ago. E.P.S. were $9.53 for the latest four quarters through September 30 versus $8.39 for the same period a year ago.
Recent Price Action
On 10/23/24, CME Group Inc (NASDAQ: CME) stock rose modestly by 0.4%, closing at $227.14. Trading volume in this advance was normal. The stock has performed in line with the market over the last nine months and has risen 1.0% during the last week.
Current PriceTarget Research Rating
CME’s future returns on capital are forecasted to exceed the cost of capital. Accordingly, the company is expected to continue to be an important Value Builder.
CME Group has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. CME Group has a poor Appreciation Score of 30 but a neutral Power Rating of 50, triggering the Negative Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment